Step 1 topics → Respiratory → NSCLC — Squamous Cell Carcinoma

NSCLC — Squamous Cell Carcinoma

USMLE Step 1 trap: Attributes hypercalcemia in squamous cell carcinoma to bone metastases rather than PTHrP secretion. Squamous cell carcinoma causes hypercalcemia via PTHrP secretion (a paraneoplastic syndrome), which mimics PTH action but is not detected on PTH assay.

Squamous cell carcinoma (SCC) of the lung is one of the high-yield NSCLC subtypes you need to know cold for USMLE Step 1. It's a central lung mass — meaning it arises near the hilum from the proximal bronchi — almost always in heavy smokers, and it cavitates. That combination (central + cavitary + smoker) is essentially its signature on a vignette. Histologically, you're looking for keratin pearls and intercellular bridges, which distinguish it from adenocarcinoma and small cell carcinoma.

The exam hits this topic from two main angles: pattern recognition (location, histology, smoking history) and clinical correlates, especially the paraneoplastic syndrome of PTHrP-mediated hypercalcemia. For the hypercalcemia angle, the vignette usually gives you a smoker with a central lung mass, an elevated calcium, and asks you to explain the mechanism or interpret labs. This is where most students get tripped up — they default to thinking about bone mets, which is wrong here.

What makes squamous cell carcinoma tricky on USMLE Step 1 is that the hypercalcemia looks like hyperparathyroidism on the surface — low phosphate, high calcium — but the PTH is suppressed, not elevated. Students who haven't built the right model for PTHrP either pick the wrong mechanism or misinterpret the lab pattern entirely. Understanding why PTH is low while calcium is high is the key to locking this down.

From real student decks
78%have cards covering this topic
54%have mature cards

Common misconceptions

Common mistake
Wrong: Hypercalcemia in squamous cell lung cancer is caused by bony metastases.
Right: Squamous cell carcinoma causes hypercalcemia via PTHrP secretion (a paraneoplastic syndrome), which mimics PTH action but is not detected on PTH assay.
Bone metastases can cause hypercalcemia, but in squamous cell carcinoma the classic mechanism is a paraneoplastic syndrome — the tumor secretes PTHrP (PTH-related peptide), which acts on PTH receptors in bone and kidney to raise calcium, completely independent of actual bony involvement. On USMLE Step 1, if the vignette says squamous cell carcinoma and hypercalcemia without specifically mentioning lytic bone lesions, default to PTHrP. Bone met hypercalcemia is more commonly tested with breast cancer and multiple myeloma.
Common mistake
Wrong: PTH levels will be elevated in PTHrP-mediated hypercalcemia.
Right: PTHrP-mediated hypercalcemia shows elevated PTHrP, suppressed PTH, elevated calcium, and low phosphate; standard PTH immunoassays do not detect PTHrP.
PTHrP mimics PTH at the receptor level, but it is a structurally distinct protein and is NOT detected by standard PTH immunoassays. This means your PTH level will actually be suppressed — the body senses high calcium and shuts down normal parathyroid secretion, while the tumor keeps pumping out PTHrP unchecked. The resulting lab pattern is: high Ca²⁺, low phosphate (PTHrP causes phosphaturia just like PTH), suppressed PTH, and elevated PTHrP on the specific assay. If you see elevated PTH alongside high calcium, think primary hyperparathyroidism, not cancer.
Free Deck audit

See if your Anki deck covers this topic.

Upload your deck →
Guided session

Stuck on this? An AI tutor that probes your understanding.

Start a session →

What the exam tests

  1. Given a vignette describing a central, cavitary lung mass in a heavy smoker, identify squamous cell carcinoma and know its characteristic histologic features (keratin pearls, intercellular bridges).
  2. Given a patient with squamous cell carcinoma and hypercalcemia, correctly identify PTHrP secretion — not bone metastases — as the mechanism, and interpret the expected lab pattern: high calcium, low phosphate, suppressed PTH, and elevated PTHrP.

Can you avoid these mistakes?

A 62-year-old man with a 45 pack-year smoking history has a central hilar mass with cavitation on CT. Biopsy shows nests of cells with keratin pearls. What is the diagnosis, and what paraneoplastic complication should you anticipate?
A patient with a known lung mass has Ca²⁺ of 12.5 mg/dL, phosphate of 1.8 mg/dL, and PTH that is undetectable. PTHrP comes back elevated. What is the mechanism of hypercalcemia, and which lung cancer subtype is most associated with this?
You order a PTH level on a patient with hypercalcemia and a central lung mass — it comes back normal/low. A classmate says this rules out a PTH-mediated process. Are they right? What should you order next and why?
Compare the expected lab findings in PTHrP-mediated hypercalcemia versus primary hyperparathyroidism: what is similar, what is different, and how do you tell them apart?

Related topics

Lung Cancer Overview and Screening Lung Development Stages Surfactant Production and Neonatal RDS Bronchopulmonary Dysplasia Congenital Diaphragmatic Hernia

See how your Anki deck covers this topic.

Upload your deck for a free audit →